Addiction and Hallucinogens

The worldwide use of psychoactive substances remains a major public health problem. It has spread in an unusual way in recent times. The methodology of this book was based on taking information from its source, where a sample of consumers of psychoactive substances (hallucinogens). The patient profile is characterized by their young age (48%), young adults [21-25 years], male predominance (82%), versus (18%) females. Pregabalin® was the most commonly used substance (59%), followed by Tramadol® (18%). The distribution of patients according to daily dose shows a high rate of 2 doses per day (35%), with an age of consumption of more than 5 years, central nervous system disorders (33%) and other disorders. Management is marked by the presence of a relatively good treatment protocol in the department, despite the absence of excellent conditions for treatment, and drug testing.

Autorentext

Doktor Salim GASMI, doktor filosofii po kletochnoj toxikologii w Uniwersitete Larbi Tebessi, Alzhir. On rabotaet nad toxicheskim wozdejstwiem lekarstw, pesticidow, xenobiotikow, nanochastic i mnogih drugih toxichnyh weschestw na organizmy, a takzhe nad profilakticheskim wozdejstwiem prirodnyh molekul, takih kak polifenoly (okislitel'nyj stress, apoptoz, mitohondrii, kletochnaq disfunkciq, powedencheskie izmeneniq.